Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas

Oral Oncology

Volumn 35, Issue 5, 1999, Pages 484-489

  Stoll, C ^a   Baretton, G ^b   Soost, F ^a   Terpe, H J ^c   Domide, P ^b   Lohrs U ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

CD44 variants; Grading; Immunohistochemistry; Metastasis; Oral; Prognosis; Squamous cell carcinoma

Indexed keywords

CD44V ANTIGEN; CELL ADHESION MOLECULE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER STAGING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RNA SPLICING;

EID: 0032781946     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00021-4     Document Type: Article

References (48)

1. Fröhlich M. Epidemiologie der Lippen- und Mundschleimhautkarzinome. Medizin aktuell. 17:1991;180-181.
2. Sobin, LH, Wittekind, C, editors. UICC TNM Classification of Malignant Tumours, 5th Edition. New York: Wiley-Liss, 1997, p. 17-32.
3. Pindborg, JJ, Reichart, PA, Smith, CJ, van der Waal, I, editors. Histological typing of cancer and precancer of the oral mucosa, 2nd Edition. Berlin: Springer, 1997, p. 11-13.
4. Honn K.V., Tang D.G. Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer and Metastasis Reviews. 11:1992;353-375.
5. Terpe H.J., Stark H., Prehm P., Günthert U. CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues. Histochemistry. 101:1994;79-89.
6. Zetter B.R. Adhesion molecules in tumor metastasis. Seminars in Cancer Biology. 4:1993;219-229.
7. Günthert U., Hofmann M., Rudy W.et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:1991;13-24.
8. Seiter S., Arch R., Reber S.et al. Prevention of tumor metastasis formation by anti-variant CD44. Journal of Experimental Medicine. 177:1993;443-455.
9. Bier J. Definition zum radikalchirurgischen Vorgehen bei Plattenepithelkarzinomen der Mundhöhle. Deutsche Zeitschrift für Mund-, Kiefer- und Gesichtschirurgie. 6:1982;369-372.
10. Piffko J., Bankfalvi A., Öfner D., Joos U., Böcker W., Schmidt K.W. Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval. Journal of Pathology. 176:1995;69-75.
11. Mackay C.R., Terpe H.J., Stauder R., Marston W.L., Stark H., Günthert U. Expression and modulation of CD44 variant isoforms in humans. Journal of Cell Biology. 124:1994;71-82.
12. Cordell J.L., Falini B., Erber W.N.et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). The Journal of Histochemistry and Cytochemistry. 32:1984;219-229.
13. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. American Statistical Association Journal. 53:1958;457-481.
14. Gehan E.H. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika. 52:1965;203-223.
15. Mantel N. Ranking procedures for arbitrarily restricted observations. Biometrics. 23:1967;65-78.
16. Cox D.R. Regression models and life-tables (with discussion). Journal of the Royal Statistical Society. 34:1972;187-220.
17. Mann H.B., Whitney D.R. On a test of whether one of two random variables is stochastically larger than the other. Annals of Mathematical Statistics. 18:1947;50-60.
18. Brown T.A., Bouchard T., St John T., Wayner E., Carter W.G. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. Journal of Cell Biology. 113:1991;207-221.
19. Hudson D.L., Sleeman J., Watt F.M. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. Journal of Cell Science. 108:1995;1959-1970.
20. Kugelman L.C, Gangulym S., Haggerty J.G., Weissman S.M., Milstone L.M. The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD44. The Journal of Investigative Dermatology. 99:1992;381-385.
21. Oliveira D.T., Odell E.W. Expression of CD44 variant exons by normal oral epithelia. Oral Oncology. 33:1997;260-262.
22. Zöller M. CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation. Journal of Molecular Medicine. 73:1995;425-438.
23. Mayer B., Jauch K.W., Günthert U.et al. De-novo expression of CD44 and survival in gastric cancer. The Lancet. 342:1993;1019-1022.
24. Streit M., Schmidt R., Hilgenfeld R.U., Thiel E., Kreuser E.D. Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. Journal of Molecular Medicine. 74:1996;253-268.
25. Washington K., Gottfried M.R., Telen M.J. Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Human Pathology. 25:1994;1043-1049.
26. Yamaguchi A., Urano T., Goi T.et al. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. Journal of Clinical Oncology. 14:1996;1122-1127.
27. Dall P., Heider K.H., Sinn H.P.et al. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. International Journal of Cancer. 60:1995;471-477.
28. Kaufmann M., Heider K.H., Sinn H.P., von Minckwitz G., Ponta H., Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. The Lancet. 345:1995;615-619.
29. Kainz C., Tempfer C., Kohlberger P.et al. lmmunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. International Journal of Cancer. 69:1996;170-173.
30. Tempfer C., Gitsch G., Haeusler G., Reinthaller A., Koelbl H., Kainz C. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva. Cancer. 78:1996;273-277.
31. Eisterer W., Hilbe W., Stauder R., Bechter O., Fend F., Thaler J. An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c. British Journal of Haematology. 93:1996;661-669.
32. Stauder R., Eisterer W., Thaler J., Günthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood. 85:1995;2885-2899.
33. Sliutz G., Tempfer C., Winkler S., Kohlberger P., Reinthaller A., Kainz C. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. British Journal of Cancer. 72:1995;1494-1497.
34. Givehchian M., Woerner S.M., Lacroix J.et al. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis. Oncogene. 12:1996;1137-1144.
35. Terpe H.J., Storkel S., Zimmer U.et al. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. American Journal of Pathology. 148:1996;453-463.
36. Birch M., Mitchell S., Hart I.R. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Research. 51:1991;6660-6667.
37. Korabiowska M., Brinck U., Honig J., Mora O., Bartkowski S., Schauer A. CD44: a marker of metastases of head and neck melanomas. In Vivo. 9:1995;253-256.
38. Combaret V., Lasset C., Frappaz D.et al. Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors. European Journal of Cancer. 31A:1995;545-549.
39. Terpe H.J., Christiansen H., Gonzalez M., Berthold F., Lampert F. Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s. European Journal of Cancer. 31A:1995;549-552.
40. Seiter S., Tilgen W., Herrmann K.et al. Expression of CD44 splice variants in human skin and epidermal tumours. Virchows Archiv. 428:1996;141-149.
41. Spafford M.F., Koeppe J., Pan Z., Archer P.G., Meyers A.D., Franklin W.A. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Archives of Otolaryngology - Head and Neck Surgery. 122:1996;627-632.
42. Kunishi M., Kayada Y., Yoshiga K. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. International Journal of Oral and Maxillofacial Surgery. 26:1997;280-283.
43. Soukka T., Salmi M., Joensuu H.et al. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Research. 57:1997;2281-2289.
44. Milstone L.M., Hough-Monroe L., Kugelman L.C., Bender J.R., Haggerty J.G. Epican, a heparan/chondroitin sulfate proteoglycan form of CD44, mediates cell-cell adhesion. Journal of Cell Science. 107:1994;3183-3190.
45. Herold Mende C., Seiter S., Born Alet al. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. Journal of Pathology. 179:1996;66-73.
46. Hudson D.L., Speight P.M., Watt F.M. Altered expression of CD44 isoforms in squamous cell carcinomas and cell lines derived from them. International Journal of Cancer. 66:1996;457-463.
47. Salmi M., Grön-Virta K., Sointu P., Grenman R., Kalimo H., Jalkanen S. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumours of squamocellular origin. Journal of Cell Biology. 122:1993;431-442.
48. Friedrichs K., Franke F., Lisboa B.W.et al. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Research. 55:1995;5424-5433.